Company intelligence / Profile preview

DIAN DIAGNOSTICS

Hangzhou, Zhejiang, Chinaen.dazd.cn ↗

Ownership: Private
Employees: ~10000
Development stage: Commercial

Overview

DIAN DIAGNOSTICS operates one of China’s largest independent third-party medical diagnostics networks. It manages over 40 laboratories serving more than 22,000 medical institutions nationwide with daily sample processing capacity exceeding 250,000 samples. The group offers more than 4,000 different test parameters and has served over 330 million people to date. No clinical trial results are relevant since it does not develop therapeutics.

Therapeutic areas: Other
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on DIAN DIAGNOSTICS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DIAN DIAGNOSTICS.

Explore the full profile